SEC Form D · filed June 7, 2021
Bolt Biotherapeutics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (35)
James Healy · Redwood City, CADirectorEdith Perez · Redwood City, CAExecEdgar Engleman · Redwood City, CADirectorMahendra Shah · Redwood City, CADirectorAshish Khanna · Redwood City, CADirectorRichard Miller · Redwood City, CADirectorGrant Yonehiro · Redwood City, CAExecWilliam Quinn · Redwood City, CAExecKathleen Laporte · Redwood City, CADirectorRandall Schatzman · Redwood City, CAExec · DirectorDavid Dornan · Redwood City, CAExecValerie Smith · Spokane, WAExecMichael J. Blazina · St. Peter Port, Y7DirectorLou Malice · CARLSBAD, CADirectorAndrew Salter · Nashville, TNExecBrennon Poynor · Spokane, WADirectorDavid Mattei · Norwalk, CTExecKara Odegard · Spokane, WADirectorRobert Mcmahon · Norwalk, CTExecAtandra Burman · CARLSBAD, CADirectorNicole J. Ramroop · Grand Cayman, Cayman IslandsDirectorMatthew Jill · New York, NYExec · DirectorPeter Moldt · San Mateo, CADirectorKen Firtel · El Segundo, CAExecHamet Watt · Playa Vista, CAExecGary A. Stein · SAN ANTONIO, TXExecBoone Dupree · Atlanta, GAExec · DirectorPankaj Jain · MANHASSET, NYDirectorCarolyn Drayer-Greenwalt · MENLO PARK, CADirectorYafit Schwartz · Tel Aviv, L3DirectorMaya Pizov · Tel Aviv, L3DirectorBenjamin Rabinowitz · Tel Aviv, L3DirectorRichard A. Cook · SAN ANTONIO, TXDirectorYuri Frayman · Hermosa Beach, CAExecPeter Moldt · San Carlos, CADirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗